Saitama, Japan

Takeshi Uzuo

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Ci., Ltd.. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeshi Uzuo

Introduction

Takeshi Uzuo is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-psychotic drugs. His work has led to advancements that may improve the lives of many individuals suffering from mental health disorders.

Latest Patents

Takeshi Uzuo holds a patent for "Phenothiazine derivatives and anti-psychotic drugs containing the same." This patent describes new phenothiazine derivatives characterized by a general formula where R represents a straight or branched alkyl group or alkenyl group having 5-15 carbon atoms, along with their acid addition salts and anti-psychotic drugs containing these new compounds. This innovation is crucial in the ongoing search for effective treatments in psychiatry.

Career Highlights

Uzuo is currently employed at Eisai Co., Ltd., a prominent pharmaceutical company known for its commitment to research and development in the healthcare sector. His work at Eisai has allowed him to focus on creating innovative solutions that address complex medical challenges.

Collaborations

Throughout his career, Takeshi Uzuo has collaborated with esteemed colleagues such as Shizuo Kuriyama and Noriyasu Hirose. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Takeshi Uzuo's contributions to the field of pharmaceuticals, particularly through his patent on phenothiazine derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in anti-psychotic treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…